Treatment of congestion using steroids and adrenergics

Details Treatment of congestion using steroids and adrenergics Treatment of congestion using steroids and adrenergics

2011-03-08

2011-03-08

Padmanabhan, Sreeni (Department: 1627)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

C514S649000

Reexamination Certificate

active

07902177

ABSTRACT:
A decongestant composition is provided comprising: (a) a safe and effective amount of an adrenergic compound; (b) a safe and effective amount of a steroid; and (c) a pharmaceutically-acceptable carrier. Methods of treating congestion in a human or animal subject are also provided comprising administering to the subject a composition comprising: (a) an adrenergic compound; and (b) a steroid; where the daily dose of the adrenergic compound administered to the subject is from about 1 μg to about 800 μg, and the daily dose of the steroid administered to the subject is from about 1 μg to about 400 μg.

REFERENCES:
patent: 4940728 (1990-07-01), Postley
patent: 5492689 (1996-02-01), Gwaltney, Jr.
patent: 5830490 (1998-11-01), Weinstein et al.
patent: 6410583 (2002-06-01), Labelle et al.
patent: 6641799 (2003-11-01), Goldberg
patent: 6843372 (2005-01-01), Weinstein
patent: 2002/0061281 (2002-05-01), Osbakken et al.
patent: 2004/0053902 (2004-03-01), Smith
patent: 2004/0235807 (2004-11-01), Weinrich et al.
patent: 2006/0030550 (2006-02-01), Lithgow et al.
patent: 19924525 (2000-11-01), None
patent: 1192853 (1970-05-01), None
Ferguson, “A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa”, Otolaryngology-Head and Neck Surgery, vol. 125, Issue 3, Sep. 2001, pp. 253-260.
Physician's Desk Reference 57th Edition, Beconase Inhalation Aerosol (2003) p. 1480-1481.
Physician's Desk Reference 57th Edition, Beconase AQ Nasal Spray (2003) p. 1481-1482.
Physician's Desk Reference 57th Edition, Flonase Nasal Spray (2003) p. 1521-1523.
Physician's Desk Reference 57th Edition, Nasacort Nasal Inhaler (2003) p. 744-746.
Physician's Desk Reference 57th Edition, Nasacort AQ Nasal Spray (2003) p. 746-747.
Physician's Desk Reference 57th Edition, Nasarel Nasal Solution 0.025% (2003) p. 1764-1766.
Physician's Desk Reference 57th Edition, Nasonex Nasal Spray (2003) p. 3052-3055.
Physician's Desk Reference 57th Edition, Rhinocort Aqua Nasal Spray (2003) p. 640-642.
Physician's Desk Reference 57th Edition, Vancenase PocketHaler Nasal Inhaler (2003) p. 3083-3085.
Physician's Desk Reference 57th Edition, Vancenase AQ Nasal Spray 0.084% (2003) p. 3085-3087.
Physician's Desk Reference 57th Edition, Advair Diskus (2003) p. 1433-1439.
Physician's Desk Reference 57th Edition, Flovent Diskus (2003) p. 1526-1529.
Physician's Desk Reference 57th Edition, Flovent Inhalation Aerosol (2003) p. 1523-1526.
Physician's Desk Reference 57th Edition, Pulmicort Turbuhaler Inhalation Powder (2003) p. 636-640.

Affiliated with

Also associated with

Rating

Treatment of congestion using steroids and adrenergics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of congestion using steroids and adrenergics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of congestion using steroids and adrenergics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2777323